Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB-DYYB Cause Drug ineffective? 3,112 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 3,112 reports of Drug ineffective have been filed in association with INFLIXIMAB-DYYB (ZYMFENTRA). This represents 12.2% of all adverse event reports for INFLIXIMAB-DYYB.

3,112
Reports of Drug ineffective with INFLIXIMAB-DYYB
12.2%
of all INFLIXIMAB-DYYB reports
27
Deaths
854
Hospitalizations

How Dangerous Is Drug ineffective From INFLIXIMAB-DYYB?

Of the 3,112 reports, 27 (0.9%) resulted in death, 854 (27.4%) required hospitalization, and 26 (0.8%) were considered life-threatening.

Is Drug ineffective Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB-DYYB. However, 3,112 reports have been filed with the FAERS database.

What Other Side Effects Does INFLIXIMAB-DYYB Cause?

Off label use (14,256) Condition aggravated (10,275) Intentional product use issue (7,549) Inappropriate schedule of product administration (5,977) Arthralgia (4,615) Fatigue (3,111) Weight increased (2,848) Malaise (2,766) Weight decreased (2,703) Blood pressure increased (2,309)

What Other Drugs Cause Drug ineffective?

ADALIMUMAB (71,926) METHOTREXATE (70,142) ETANERCEPT (60,367) ADAPALENE (52,181) ABATACEPT (35,212) INFLIXIMAB (33,738) TOCILIZUMAB (32,342) RITUXIMAB (32,186) LEFLUNOMIDE (31,396) HYDROXYCHLOROQUINE (31,057)

Which INFLIXIMAB-DYYB Alternatives Have Lower Drug ineffective Risk?

INFLIXIMAB-DYYB vs INFLIXIMAB-QBTX INFLIXIMAB-DYYB vs INFLIXIMAB, RECOMBINANT INFLIXIMAB-DYYB vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B

Related Pages

INFLIXIMAB-DYYB Full Profile All Drug ineffective Reports All Drugs Causing Drug ineffective INFLIXIMAB-DYYB Demographics